Nutriband Inc
Research Nutriband Inc (NTRB) on Bullrun: market cap USD 39.02M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNTRB
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 39.02M
- Financial periodFY2026
- RevenueUSD 2.04M
- Revenue growth-4.8%
- Net income-USD 8.23M
- Free cash flow-USD 5.14M
- Gross margin27.8%
Valuation Snapshot
latest market cap is USD 39.02M.
About Nutriband Inc
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
Frequently asked questions
What is Nutriband Inc's market cap?
Nutriband Inc's market capitalization is USD 39.02M.
What does Nutriband Inc do?
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate.